The effect of cinnamon consumption on lipid profile, oxidative stress, and inflammation biomarkers in adults: An umbrella meta-analysis of randomized controlled trials

Nutr Metab Cardiovasc Dis. 2023 Oct;33(10):1821-1835. doi: 10.1016/j.numecd.2023.03.010. Epub 2023 Mar 18.

Abstract

Aims: Cinnamon is a polyphenol-rich spice that has beneficial effects on markers of cardio metabolic health such as lipid profile, oxidative stress, and inflammation. Despite the accumulating evidence from meta-analyses on the effects of cinnamon on these markers, their findings are controversial. Thus, this umbrella meta-analysis was performed to evaluate the present evidence and provide a conclusive clarification.

Data synthesis: We searched the following international databases from inception to January 2022: PubMed, Scopus, Web of Science and Embase, and Google Scholar. Our findings of eleven meta-analyses showed that cinnamon consumption can significantly improve total cholesterol (TC) (WMD = -1.01 mg/dL; 95% CI: -2.02, -0.00, p = 0.049), low-density lipoprotein-cholesterol (LDL-C) (WMD = -0.82 mg/dL; 95% CI: -1.57, -0.07, p = 0.032), and high-density lipoprotein-cholesterol (HDL-C) (WMD = 0.47 mg/dL; 95% CI: 0.17, 0.77, p = 0.002) levels but not triglyceride (TG) levels (WMD = -0.13 mg/dL; 95% CI: -0.58, 0.32, p = 0.570). Our results did not show any significant effect of cinnamon on malondialdehyde (MDA) levels (WMD = -0.47; 95% CI: -0.99, 0.05, p = 0.078) and C-reactive protein (CRP) levels (WMD = -1.33; 95% CI: -2.66, 0.00, p = 0.051) but there was enhanced total antioxidant capacity (TAC) in patients with type 2 diabetes (T2DM) and polycystic ovary syndrome (PCOS) (WMD = 0.34; 95% CI: 0.04, 0.64, p = 0.026) and increased levels of interleukin-6 (WMD = -1.48; 95% CI: -2.96, -0.01, p = 0.049).

Conclusions: Our results support the usefulness of cinnamon intake in modulating an imbalanced lipid profile in some metabolic disorders, particularly PCOS, as well as in improving TAC and interleukin-6. The review protocol was registered on PROSPERO as CRD42022358827.

Keywords: Cinnamon; Dyslipidemia; Inflammatory biomarkers; Lipid profile; Meta-analysis; Oxidative stress.

Publication types

  • Meta-Analysis

MeSH terms

  • Adult
  • Antioxidants / pharmacology
  • Biomarkers
  • Cholesterol
  • Cinnamomum zeylanicum
  • Diabetes Mellitus, Type 2*
  • Dietary Supplements
  • Female
  • Humans
  • Inflammation / diagnosis
  • Inflammation / drug therapy
  • Interleukin-6
  • Lipids*
  • Oxidative Stress
  • Randomized Controlled Trials as Topic

Substances

  • Antioxidants
  • Biomarkers
  • Cholesterol
  • Interleukin-6
  • Lipids